AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35870236 — intervention group
Group type: COMPARATOR
Intervention: Real-world social groups (gender or race)
Number of subjects: 192
Study 34773880 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasacral transcutaneous electrical stimulation
Number of subjects: 99
Study 34773880 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial transcutaneous electrical stimulation
Number of subjects: 99
Study 34773880 — intervention group
Group type: COMPARATOR
Intervention: Sham group (active electrode placed over the scapula)
Number of subjects: 99
Study 36038984 — intervention group
Group type: EXPERIMENTAL
Intervention: EHA cream (1% ectoine and 0.1% hyaluronic acid), applied twice daily for 4 weeks
Number of subjects: 70
Study 36038984 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream, applied twice daily for 4 weeks
Number of subjects: 70
Study 36038984 — intervention group
Group type: EXPERIMENTAL
Intervention: EHA cream (1% ectoine and 0.1% hyaluronic acid)
Number of subjects: 70
Study 36038984 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 70
Study 36038984 — intervention group
Group type: EXPERIMENTAL
Intervention: EHA cream
Number of subjects: 70
Study 32919819 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-guided individualized nutritional support during the hospital stay
Number of subjects: 1995
Study 32919819 — intervention group
Group type: COMPARATOR
Intervention: Hospital food as usual (control group)
Number of subjects: 1995
Study 35062921 — intervention group
Group type: EXPERIMENTAL
Intervention: Power 4 a Healthy Pregnancy (P4HP) intervention group
Number of subjects: 350
Study 35062921 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 350
Study 33246390 — intervention group
Group type: EXPERIMENTAL
Intervention: Family navigation
Number of subjects: 275
Study 33246390 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 275
Study 34429230 — intervention group
Group type: EXPERIMENTAL
Intervention: ultrasound + PICCO
Number of subjects: 68
Study 34429230 — intervention group
Group type: COMPARATOR
Intervention: PICCO
Number of subjects: 68
Study 33076287 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype B3 measles virus strains identified through RT-PCR amplification
Number of subjects: 3258
Study 33076287 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular surveillance
Number of subjects: 3258
Study 33076287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive vaccination program
Number of subjects: 3258
Study 32171308 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary graded exposure program
Number of subjects: 30
Study 32672654 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft-free short tunnel small flap (STSF) technique
Number of subjects: 203
Study 32672654 — intervention group
Group type: COMPARATOR
Intervention: Scleral patch graft (SPG) technique
Number of subjects: 203
Study 35060528 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus methylene blue
Number of subjects: 64
Study 35060528 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 64
Study 34151132 — intervention group
Group type: COMPARATOR
Intervention: Control group (3 months of afatinib)
Number of subjects: 46
Study 35550036 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant proton radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0
Study 35550036 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant carbon ion radiotherapy (39 Gy in 13 fractions)
Number of subjects: 0
Study 34280455 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron (0.075 mg)
Number of subjects: 212
Study 34280455 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron (8 mg)
Number of subjects: 212
Study 34280455 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 212
Study 34280455 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron and Ondansetron
Number of subjects: 212
Study 33093133 — intervention group
Group type: COMPARATOR
Intervention: Conscious sedation
Number of subjects: 368
Study 33093133 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia
Number of subjects: 368
Study 34459904 — intervention group
Group type: EXPERIMENTAL
Intervention: States that lifted eviction moratorium
Number of subjects: 509694
Study 34459904 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with Charlson Comorbidity Index score of 3 or greater
Number of subjects: 509694
Study 34459904 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals living in nonaffluent areas
Number of subjects: 509694
Study 34459904 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals living in areas with high rent burden
Number of subjects: 509694
Study 34459904 — intervention group
Group type: COMPARATOR
Intervention: States that did not lift eviction moratorium
Number of subjects: 509694
Study 36442063 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir plus SOC (ACTT-1)
Number of subjects: 0
Study 36442063 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir plus SOC (ACTT-2)
Number of subjects: 0
Study 36442063 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir plus dexamethasone plus SOC (ACTT-3)
Number of subjects: 0
Study 36442063 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus SOC (ACTT-1)
Number of subjects: 0
Study 32313940 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole-based COS
Number of subjects: 401
Study 32313940 — intervention group
Group type: COMPARATOR
Intervention: Conventional COS
Number of subjects: 401
Study 32313940 — intervention group
Group type: COMPARATOR
Intervention: Random-cycle start COS
Number of subjects: 401
Study 32313940 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa trigger
Number of subjects: 401
Study 32313940 — intervention group
Group type: EXPERIMENTAL
Intervention: Thawing of oocytes or embryos
Number of subjects: 401
Study 32313940 — intervention group
Group type: COMPARATOR
Intervention: All-cause survival
Number of subjects: 401
Study 35102203 — intervention group
Group type: COMPARATOR
Intervention: FC rt‐fMRI neurofeedback with online global signal regression (GSR)
Number of subjects: 40
Study 36401133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (NIVO + IPI)
Number of subjects: 394
Study 36401133 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus chemotherapy (NIVO + Chemo)
Number of subjects: 394
Study 36401133 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (Chemo)
Number of subjects: 394
Study 33058746 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex decongestive therapy (CDT) including manual lymphatic drainage (MLD) before bandaging, 15 sessions over 3 weeks.
Number of subjects: 54
Study 33058746 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (ST) including compressive multilayer bandaging and exercise training, 15 sessions over 3 weeks.
Number of subjects: 54
Study 32535341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (body positioning changed in the second and fourth hour after chemoembolization)
Number of subjects: 78
Study 32535341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (body positioning changed)
Number of subjects: 78
Study 32535341 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care, lying supine)
Number of subjects: 78
Study 36206832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Neuromuscular Stabilization (DNS)
Number of subjects: 64
Study 36206832 — intervention group
Group type: COMPARATOR
Intervention: Core Stabilization (CS)
Number of subjects: 64
Study 33499572 — intervention group
Group type: EXPERIMENTAL
Intervention: VR video intervention
Number of subjects: 84
Study 33499572 — intervention group
Group type: COMPARATOR
Intervention: General video intervention
Number of subjects: 84
Study 32548906 — intervention group
Group type: EXPERIMENTAL
Intervention: Fit & Strong! program (exercise combined with health education)
Number of subjects: 82
Study 32548906 — intervention group
Group type: COMPARATOR
Intervention: Non-participants (those who declined participation)
Number of subjects: 82
Study 35580566 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children with 0 components of MetS
Number of subjects: 90
Study 35580566 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children with 1 component of MetS
Number of subjects: 90
Study 35580566 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese children with 2 or more components of MetS
Number of subjects: 90
Study 35580566 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy peers)
Number of subjects: 90
Study 34022854 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined motor control and isolated extensor strengthening (MC + ILEX)
Number of subjects: 50
Study 34022854 — intervention group
Group type: COMPARATOR
Intervention: General exercise (GE)
Number of subjects: 50
Study 32388446 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine 1g/day for 1 week and 2g/day for 3 weeks
Number of subjects: 20
Study 35241047 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factors (CGF) combined with Deproteinized Bovine Bone Mineral (DBBM)
Number of subjects: 38
Study 35241047 — intervention group
Group type: COMPARATOR
Intervention: DBBM alone (Control group)
Number of subjects: 38
Study 33277845 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential chemoradiotherapy
Number of subjects: 116
Study 33277845 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy
Number of subjects: 116
Study 34344672 — intervention group
Group type: EXPERIMENTAL
Intervention: HCQ 200 mg/day + BHH 8 mg/8 hours
Number of subjects: 214
Study 34344672 — intervention group
Group type: COMPARATOR
Intervention: HCQ placebo + BHH placebo
Number of subjects: 214
Study 33262458 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid-particle-in-cell (PIC) - Monte Carlo Collision (h-PIC-MCC) algorithm
Number of subjects: 0
Study 34076333 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone (C)
Number of subjects: 491
Study 34076333 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (A)
Number of subjects: 491
Study 32586613 — intervention group
Group type: EXPERIMENTAL
Intervention: Maitland joint mobilization technique
Number of subjects: 30
Study 32586613 — intervention group
Group type: COMPARATOR
Intervention: Home based training group
Number of subjects: 30
Study 35765728 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml of 0.3% ropivacaine
Number of subjects: 40
Study 35765728 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml of 0.3% ropivacaine
Number of subjects: 40
Study 34448759 — intervention group
Group type: EXPERIMENTAL
Intervention: IPL + PDL
Number of subjects: 33
Study 34448759 — intervention group
Group type: COMPARATOR
Intervention: PDL
Number of subjects: 33
Study 33242998 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) with U-500R
Number of subjects: 0
Study 33242998 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injection (SC) of U-500R
Number of subjects: 0
Study 33199427 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-based video game intervention
Number of subjects: 0
Study 33199427 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative questionnaires
Number of subjects: 0
Study 35954926 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin (PRF)
Number of subjects: 10
Study 35954926 — intervention group
Group type: COMPARATOR
Intervention: Freeze-Dried Bone Allograft (FDBA)
Number of subjects: 10
Study 34407782 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Mobile Technology Plus (MT+) intervention
Number of subjects: 80
Study 34407782 — intervention group
Group type: COMPARATOR
Intervention: Basic Mobile Technology (MT) intervention
Number of subjects: 80
Study 32235839 — intervention group
Group type: EXPERIMENTAL
Intervention: Concise scoring method based on factors such as hyperbilirubinemia, sepsis, and ventilator and/or vasoactive support in the discovery cohort (n=4,151).
Number of subjects: 8320
Study 32235839 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation cohort scoring method.
Number of subjects: 8320
Study 34180245 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive day-camp intervention arm
Number of subjects: 115
Study 34180245 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention arm
Number of subjects: 115
Study 34989150 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute distress group
Number of subjects: 47
Study 34989150 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 34989150 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (higher emotional eating)
Number of subjects: 47
Study 34989150 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (higher emotional eating and increased acute distress)
Number of subjects: 47
Study 32086599 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐L (carbohydrate loaded)
Number of subjects: 5
Study 32086599 — intervention group
Group type: EXPERIMENTAL
Intervention: CHO‐D (carbohydrate depleted)
Number of subjects: 5
Study 33200772 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered behavioral self-regulation counseling
Number of subjects: 251
Study 33200772 — intervention group
Group type: COMPARATOR
Intervention: In-office behavioral self-regulation counseling
Number of subjects: 251
Study 33200772 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (telephone and in-office)
Number of subjects: 251
Study 33379191 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fasting (extended distribution: 522 kcal total; bulking: 512 kcal total)
Number of subjects: 17
Study 33379191 — intervention group
Group type: COMPARATOR
Intervention: True fasting (nil‐caloric intake)
Number of subjects: 17
Study 35356935 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus antihypertensive drugs
Number of subjects: 70
Study 35356935 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive drugs only
Number of subjects: 70
Study 33166769 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline glucose level
Number of subjects: 62
Study 35410189 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly Clinical Supervision for up to two years
Number of subjects: 12
Study 35410189 — intervention group
Group type: COMPARATOR
Intervention: Control sites (no Clinical Supervision)
Number of subjects: 12
Study 33631541 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (BI) plus 28 days of tailored booster messaging
Number of subjects: 63
Study 33631541 — intervention group
Group type: COMPARATOR
Intervention: Control condition (community resource brochure)
Number of subjects: 63
Study 33753657 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealants placed with bonding agent
Number of subjects: 25
Study 33753657 — intervention group
Group type: COMPARATOR
Intervention: Sealants placed without bonding agent
Number of subjects: 25
Study 35899211 — intervention group
Group type: COMPARATOR
Intervention: 5% topical minoxidil (MX) alone, once daily
Number of subjects: 120
Study 35899211 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil plus oral spironolactone (SPT) 80–100 mg daily
Number of subjects: 120
Study 35899211 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil plus microneedling (MN) every 2 weeks, 12 sessions
Number of subjects: 120
Study 35899211 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 35899211 — intervention group
Group type: EXPERIMENTAL
Intervention: MX + SPT group
Number of subjects: 120
Study 33879327 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-screen monitoring
Number of subjects: 52
Study 33879327 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatar monitoring
Number of subjects: 52
Study 33879327 — intervention group
Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 52
Study 35873768 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee group (caffeine-containing beverage)
Number of subjects: 40
Study 35873768 — intervention group
Group type: COMPARATOR
Intervention: Juice group (non-caffeinated juice)
Number of subjects: 40
Study 35873768 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pre- and post-EA)
Number of subjects: 40
Study 35873768 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (week 4)
Number of subjects: 40
Study 35873768 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (week 2)
Number of subjects: 40
Study 34719299 — intervention group
Group type: EXPERIMENTAL
Intervention: Web app
Number of subjects: 34
Study 33115487 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Environments and wearable haptic devices (VERA)
Number of subjects: 8
Study 33115487 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (manual therapy)
Number of subjects: 8
Study 35922096 — intervention group
Group type: EXPERIMENTAL
Intervention: IG1
Number of subjects: 4268
Study 35922096 — intervention group
Group type: EXPERIMENTAL
Intervention: IG2
Number of subjects: 4268
Study 35922096 — intervention group
Group type: EXPERIMENTAL
Intervention: IG3
Number of subjects: 4268
Study 35922096 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 4268
Study 32894643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/velpatasvir (SOF/VEL)
Number of subjects: 1427
Study 32894643 — intervention group
Group type: COMPARATOR
Intervention: Sofosbuvir/ledipasvir (SOF/LDV)
Number of subjects: 1427
Study 33217416 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume mechanical ventilation (3 mL/kg 5 times/min, with positive end expiratory pressure of 5 cm H2O) during CPB
Number of subjects: 1501
Study 33217416 — intervention group
Group type: COMPARATOR
Intervention: No ventilation strategy during CPB
Number of subjects: 1501
Study 33217416 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume mechanical ventilation during CPB
Number of subjects: 1501
Study 33034145 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam (single dose 1–2 hours before frozen-thawed ET)
Number of subjects: 178
Study 33034145 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered at the same time as piroxicam)
Number of subjects: 178
Study 34420261 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonized water irrigation
Number of subjects: 50
Study 34420261 — intervention group
Group type: COMPARATOR
Intervention: Normal saline irrigation
Number of subjects: 50
Study 32275720 — intervention group
Group type: EXPERIMENTAL
Intervention: Height (measured in centimeters)
Number of subjects: 3427
Study 32275720 — intervention group
Group type: COMPARATOR
Intervention: Cognitive/noncognitive skills (mental health, risk preference, personality factors)
Number of subjects: 3427
Study 32503502 — intervention group
Group type: EXPERIMENTAL
Intervention: New oral composition
Number of subjects: 105
Study 32503502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 35110393 — intervention group
Group type: COMPARATOR
Intervention: CVN424 (1 mg to 225 mg single doses; 25, 75, or 150 mg repeated daily doses for 7 days)
Number of subjects: 0
Study 35110393 — intervention group
Group type: COMPARATOR
Intervention: CVN424 (dosing after a standardized high-fat meal)
Number of subjects: 0
Study 35110393 — intervention group
Group type: COMPARATOR
Intervention: CVN424 (various doses)
Number of subjects: 0
Study 33652705 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic load diet (n = 28)
Number of subjects: 62
Study 33652705 — intervention group
Group type: COMPARATOR
Intervention: High-glycemic load diet (n = 34)
Number of subjects: 62
Study 33805076 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered diet program for stroke survivors
Number of subjects: 18
Study 33805076 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-design workshops
Number of subjects: 18
Study 33805076 — intervention group
Group type: EXPERIMENTAL
Intervention: Support framework and resources specific to outcome of stroke
Number of subjects: 18
Study 33177181 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen formulated with adjuvant AS01B
Number of subjects: 0
Study 33177181 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen formulated with adjuvant AS01E
Number of subjects: 0
Study 33177181 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen formulated with adjuvant AS03
Number of subjects: 0
Study 35567630 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% nitrilotriacetic acid trisodium salt
Number of subjects: 58
Study 35567630 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 58
Study 32708864 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary residential nutritional rehabilitation program
Number of subjects: 71
Study 32708864 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 71
Study 34969004 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane (TAP) blocks with liposomal bupivacaine
Number of subjects: 498
Study 34969004 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 498
Study 33264769 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH)
Number of subjects: 170
Study 33264769 — intervention group
Group type: COMPARATOR
Intervention: All other modalities
Number of subjects: 170
Study 33038007 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical niacinamide
Number of subjects: 0
Study 33038007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35761212 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded individualised multicomponent frailty intervention (extra sessions of physiotherapy, pharmacy, and dietetics during admission)
Number of subjects: 732
Study 35761212 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded individualised multicomponent frailty intervention
Number of subjects: 732
Study 33226176 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064-nm Nd:YAG laser
Number of subjects: 34
Study 33226176 — intervention group
Group type: COMPARATOR
Intervention: 595-nm pulsed dye laser (PDL)
Number of subjects: 34
Study 33736903 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST
Number of subjects: 395
Study 33736903 — intervention group
Group type: COMPARATOR
Intervention: Stroke-112
Number of subjects: 395
Study 32589515 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridge-enhanced ACL repair
Number of subjects: 65